News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Novo Nordisk warns 2026 sales and operating profit will decline, sending shares down ~16% and erasing about $50 billion in market value.
  • Russia faces a budget gap widening to 3.5–4.4% of GDP in 2026 as oil revenues fall, signaling fiscal stress and reserve drawdowns.
  • Clear Street targets a U.S. IPO valuing the broker up to $11.8 billion, aiming to raise up to $1.05 billion on Nasdaq.
  • Live Nation agrees to buy Italy's ForumNet for about €90 million enterprise value, expanding its Italian venue footprint.
  • Jefferies highlights European capital-goods names set to benefit from data center, power and automation demand, naming Siemens and peers.
  • Kingstone posts preliminary record Q4 and 2025 results, lifting stock about 10% ahead of a March 6 earnings call.
  • BofA upgrades Five Below to Buy, raising its price target and signaling confidence in execution improvements under new management.

Latest Articles

Dollar Pauses After Sharp Slide as Policy Signals and Market Moves Collide

Dollar Pauses After Sharp Slide as Policy Signals and Market Moves Collide

The dollar steadied on Wednesday following a steep decline to a four-year low overnight, a move that President Donald Trump publicly welcomed as the currency being "great" and that it should "just seek its own level." Markets are weighing whether the administration prefers a weaker dollar while Treasury Secretary Scott Bessent has remained tight-li…

Eikon Therapeutics Seeks $908.2 Million Valuation in U.S. IPO

Eikon Therapeutics Seeks $908.2 Million Valuation in U.S. IPO

On Jan. 28, Eikon Therapeutics filed to pursue a U.S. initial public offering that would value the company at as much as $908.2 million and raise up to $317.7 million by selling 17.65 million shares at $16 to $18 apiece. The Millbrae, California-based drug developer is advancing a cancer pipeline led by EIK1001, being evaluated in combination with …

London Stocks Slip as Healthcare and Banks Weigh on FTSE 100

London Stocks Slip as Healthcare and Banks Weigh on FTSE 100

On Jan 28 the FTSE 100 declined as losses in healthcare and bank shares offset gains in miners and energy names. The domestically focused FTSE 250 rose, hitting its highest level since January 2022 earlier in the session. Market attention centred on corporate earnings and an awaited U.S. Federal Reserve policy update.

RLAY Trade Setup: Upgrade Heat Meets a High-Short-Interest Tape

RLAY Trade Setup: Upgrade Heat Meets a High-Short-Interest Tape

Relay Therapeutics is catching a bid as optimism builds around zovegalisib (RLY-2608). With shares back near the top of the 52-week range and short interest still heavy, the next move likely comes down to whether price can hold above key moving averages and push through recent resistance. Here’s a defined long trade with a tight invalidation level …

AT&T Lays Infrastructure Bets, Sees 2026 Profit Above Street Estimates

AT&T Lays Infrastructure Bets, Sees 2026 Profit Above Street Estimates

AT&T said it expects 2026 adjusted earnings per share to exceed analyst forecasts, attributing the upbeat outlook to planned network investments including the acquisition of Lumen’s consumer fiber assets and EchoStar’s spectrum licenses. The company reported healthy fiber and wireless additions in the fourth quarter and will consolidate 5G and fibe…

China’s Wang Yi Tells France China and EU Are Partners, Not Rivals

China’s Wang Yi Tells France China and EU Are Partners, Not Rivals

China’s Foreign Minister Wang Yi told Emmanuel Bonne, the diplomatic adviser to the French president, that China and the European Union are partners rather than rivals during a telephone conversation on Wednesday. Wang said Beijing and the EU share positions on promoting a multipolar world, advocated resolving trade disputes through dialogue, and u…

Stellantis Deepens Price Cuts in France to Drive Volume Recovery

Stellantis Deepens Price Cuts in France to Drive Volume Recovery

Stellantis said it will step up price reductions on new cars in France, accelerating a program that began in late 2025. The move, announced by the head of Stellantis France, aims to rebuild vehicle sales volumes in the company's largest European market, with discounts already applied to several small car models.

Wells Fargo Wealth Unit Ends Relationship with Proxy Adviser ISS

Wells Fargo Wealth Unit Ends Relationship with Proxy Adviser ISS

Wells Fargo's wealth and investment management division has cut ties with the proxy advisory firm Institutional Shareholder Services (ISS) and will shift to making voting decisions on shareholder proposals using a newly developed in-house process. The move follows similar recent changes among large asset managers and comes amid intensified scrutiny…

Eikon Therapeutics Seeks Up to $908.2 Million Valuation in Planned U.S. IPO

Eikon Therapeutics Seeks Up to $908.2 Million Valuation in Planned U.S. IPO

Eikon Therapeutics has filed for a U.S. initial public offering that would value the company at as much as $908.2 million. The Millbrae, California-based drug developer plans to sell 17.65 million shares at $16 to $18 apiece, aiming to raise up to $317.7 million and list on the Nasdaq under the symbol EIKN as the biotech IPO pipeline gains momentum…

Baird Starts Coverage on Coinbase With Neutral Rating and $240 Target

Baird Starts Coverage on Coinbase With Neutral Rating and $240 Target

Baird has launched coverage of Coinbase Global Inc. (COIN) with a Neutral rating and a $240 price target, citing the company's leading U.S. exchange franchise, strong recent revenue growth and a number of growth initiatives. The firm said risk and reward appear balanced given recent trading-volume deterioration and regulatory uncertainty, while oth…

Rising Bank Lending Strengthens Case for Fed Rate Patience

Rising Bank Lending Strengthens Case for Fed Rate Patience

Stronger demand for bank credit, documented in recent surveys and quarterly bank reports, is easing financial conditions and could reduce urgency for the Federal Reserve to lower its policy rate. Policymakers remain focused on inflation and labor-market metrics, but growing lending activity provides an additional reason to hold rates for now.